New agar medium for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide

Journal of Clinical Microbiology

Volumn 38, Issue 4, 2000, Pages 1498-1501

  Heifets, Leonid ^a,b   Sanchez, Tracy ^a  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; PYRAZINAMIDE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PH MEASUREMENT; PRIORITY JOURNAL; STRAIN DIFFERENCE;

ACTINOBACTERIA (CLASS); ANIMALIA; BACTERIA (MICROORGANISMS); BOVINAE; EQUIDAE; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; UNCULTURED ACTINOMYCETE;

EID: 0034000726     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.38.4.1498-1501.2000     Document Type: Article

References (12)

1. Butler, W. R., and J. O. Kilburn. 1982. Improved method for testing susceptibility of Mycobacterium tuberculosis to pyrazimimide. J. Clin. Microbiol. 16:1106-1109.
2. Butler, W. R., and J. O. Kilburn. 1983. Susceptibility of Mycobacterium tuberculosis to pyrazinamide and its relationship to pyrazinamidase activity. Antimicrob. Agents Chemother. 24:600-601.
3. Heifets, L., and J. Cangelosi. 1999. Drug susceptibility testing of Mycobacterium tuberculosis: a neglected problem at the turn of the century. Int. J. Tuberc. Lung Dis. 3:564-581.
4. Heifets, L. B. 1991. Drug susceptibility tests in the management of chemotherapy of tuberculosis, p. 89-122. In L. B. Heifets (ed.), Drug susceptibility in the chemotherapy of mycobacterial infections. CRC Press, Boca Raton, Fla.
5. Hewlett, D., D. Horn, and C. Alfalla. 1995. Drug-resistant tuberculosis: inconsistent results of pyrazinamide susceptibility testing. JAMA 273:916-917. (Letter.)
6. Miller, M. A., L. Thibert, F. Desjardins, S. H. Siddiqi, and A. Dascal. 1996. Growth inhibition of Mycobacterium tuberculosis by polyoxyethylene stearate present in the BACTEC pyrazinamide susceptibility test. J. Clin. Microbiol. 34:84-86.
7. Saifinger, M., and L. Heifets. 1988. Determination of pyrazinamide MICs for Mycobacterium tuberculosis at different pHs by the radiometric method. Antimicrob. Agents Chemother. 32:1002-1004.
8. Scorpio, A., P. Lindholm-Levy, L. Heifets, R. Gilman, S. Siddiqi, M. Cynamon, and Y. Zhang. 1997. Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 41:540-543.
9. Scorpio, A., and A. Zhang. 1996. Mutations of pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus. Nat. Med. 2:662-667.
10. Siddiqi, S. 1992. Radiometric (BACTEC) tests for slowly growing mycobacteria, p. 1-25. In H. Isenberg (ed.), Clinical microbiology procedures handbook, vol. 5.14. American Society for Microbiology, Washington, D.C.
11. Stottmeier, K. D., R. E. Beam, and G. P. Kubica. 1967. Determination of drug susceptibility of mycobacteria to pyrazinamide in 7H10 agar. Am. Rev. Respir. Dis. 96:1072-1075.
12. Tenover, F. C., J. T. Crawford, R. E. Heubner, L. J. Geiter, C. R. Horsburgh, and R. C. Good. 1993. The resurgence of tuberculosis: is your laboratory ready? J. Clin. Microbiol. 31:767-770.